Side effects reported in the literature are rare and generally mild, limited to transient redness or a slight tingling sensation upon topical application
A., Breathett, K., Brouse, S., Butler, J., et al
CJC-1295 (no-DAC) is a stabilised GHRH 1-29 analogue that activates the GHRH receptor
Readers who are also comparing options during or after treatment sometimes look into related topics such as how Ozempic affects blood sugar, Mounjaro and muscle loss, or how Zepbound works for weight loss as they think through next steps
All results given concern published clinical trials of the cagrilintide + semaglutide combination and should not be interpreted as a promise of effect, an instruction for use or a claim about the effect of the research-grade product offered by Peptology